Lamotrigina Doc (Lamotrigine)

Lamotrigine works by blocking voltage‑gated sodium channels on neurons, which reduces the influx of sodium ions during depolarisation. This stabilises neuronal membranes and limits the release of excitatory neurotransmitters such as glutamate, thereby decreasing abnormal neuronal firing that underlies seizures and mood swings.

The dose of Lamotrigina Doc is individualised by the prescribing clinician based on the patient’s age, weight, renal and hepatic function, and the specific indication. Titration is usually performed gradually to minimise the risk of rash, and the exact regimen should follow the prescriber’s instructions.

Data on lamotrigine use in pregnancy are limited, and the drug is classified as pregnancy category unknown. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus. Lamotrigine is excreted in breast milk, so breastfeeding mothers should discuss risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the Lamotrigina Doc product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details and any required import documentation.

Compared with older agents such as carbamazepine or valproic acid, lamotrigine has a favourable side‑effect profile, particularly a lower risk of weight gain and sedation. However, it carries a unique risk of severe skin reactions, especially during rapid dose escalation. Choice of therapy depends on the seizure type, comorbidities and individual tolerability.

Lamotrigina Doc should be stored at ambient temperature, below 25 °C, in its original container. Protect the tablets from moisture, heat and direct sunlight. Keep out of reach of children and do not use after the expiration date printed on the packaging.

Lamotrigina Doc is taken orally as a tablet. Swallow the tablet whole with a glass of water; it may be taken with or without food. Dosage adjustments should follow the prescriber’s titration schedule, and the tablets should not be crushed or chewed unless specifically advised.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, which can be life‑threatening. Other rare but serious events are blood dyscrasias like agranulocytosis and severe hepatic injury. Immediate medical attention is required if a rash or systemic symptoms develop.

Lamotrigine is contraindicated in individuals with a known hypersensitivity to the drug or any of its components. Patients with a history of severe skin reactions to lamotrigine or other anticonvulsants should avoid it. Caution is also advised in patients with severe hepatic impairment, as metabolism may be markedly reduced.